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Over a century ago, Elie Metchnikoff theorized that health could be enhanced and senil-
ity delayed by manipulating the intestinal microbiome with host-friendly bacteria found
in yogurt. His theory flourished for a time, then drifted to the fringe of medical practice
before re-emerging in the mid-1990s as a concept worthy of mainstream medical attention.
Metchnikoff also predicted the existence of bacterial translocation and anticipated theories
linking chronic inflammation with the pathogenesis of atherosclerosis and other disorders
of the aged.
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“The promise of microbiome research results largely on the
future of probiotics. . .. Eventually, it may become possible to
restore the health of a depleted microbiome simply by swal-
lowing a capsule crammed with billions of bacterial cells, or
by eating yogurt (1).”
Although Michael Specter implied otherwise in his article in The
New Yorker (1), neither microbiome research nor the use of probi-
otics to promote health is new. Over a century ago, Ilya Ilyich (Élie)
Metchnikoff (Figure 1) theorized that health could be enhanced,
and also that senility could be delayed, by manipulating the intesti-
nal microbiome with host-friendly bacteria found in yogurt (2).
His theory flourished for a time, then drifted to the fringe of med-
ical practice, only to re-emerge in the mid-1990s as a concept
worthy of mainstream medical attention. Today probiotics are not
only the subject of intense medical research but also the source of a
multi-billion dollar global industry (3). The microbiome now has
a N.I.H.-funded Human-Microbiome Project1, as well as a new
peer-reviewed journal devoted to it exclusively2.
Metchnikoff ’s concepts laid the foundation for fecal transplan-
tation, predicted the existence of bacterial translocation from the
intestinal lumen into the bloodstream and lymphatic system, and
anticipated theories linking chronic inflammation with the patho-
genesis of atherosclerosis (2). His concepts have also been invoked
in modern times by fringe groups, such as the medical ecologists,
attributing a host of chronic disabilities to intestinal proliferation
of Candida sp. (4).
Elie Metchnikoff was born on May 3, 1845 near Kharkow, Rus-
sia (now part of Ukraine). He studied at the university there from
1862 to 1864 before traveling to Germany where he trained in
1http://www.human-microbiome.org/
2http://www.eurekalert.org/pub_releases/2013-01/uod-gsl010913.php
comparative anatomy at universities in Giessen, Gottingen and
Munich. In 1870 he accepted a professorship at the University of
Odessa, worked there for 12 years, and then resigned his post to
begin an odyssey that took him from Madeira to Teneriffe to the
Volga. It was during these wandering years that he published his
opus magnum, “Intracellular Digestion in Invertebrate Animals,”
in Arberten of the Zoological Institute of Vienna. In it he sum-
marized studies demonstrating clearance of foreign particles from
the tissues of lower animals by devouring cells he called “phago-
cytes,” which he came to realize were critical in protecting the host
animal against infection. The work earned him an appointment as
Pasteur’s successor as Director of Scientific Research at the Pasteur
Institute, a Nobel Prize in 1908, and immortality as the father of
cellular immunology (2).
Late in his career, as his vigor began to ebb, Metchnikoff turned
his attention to the mechanisms responsible for senility and the
means by which they might be inhibited. His ideas concerning
these issues were dominated by both his work with phagocytes
and his own ascetic life style (2).
In contemplating questions related to senility, Metchnikoff ’s
attention was drawn to the residents of Eastern Europe, in par-
ticular those of the Balkan States and Russia, among whom there
existed an unusually large number of centenarians. He was struck
by the fact that citizens of that region who lived to the age of 100
were, for the most part, poor or of humble circumstances with
extremely simple life styles. This convinced him that the secrets to
a long, productive life included a simple, sober existence, “mod-
erate in food and drink and in all other pleasures,” complimented
by daily exercised “whatever be the weather. . . lived in a peaceful
environment in which the air is pure. . . going to bed early and
rising early after not more than 6–7 h of sleep, bathing daily with
water neither too hot nor too cold, engaging in regular work and
mental stimulation, and avoiding alcohol, other stimulants and
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FIGURE 1 | Elie Metchnikoff (1845–1916).
narcotics (2).” Few today would argue with any aspect of Metch-
nikoff ’s concept of a healthy life style, with the possible exception
of his proscription against alcohol, given the current excitement
over the possibility that red wine might be cardio-protective (5).
Macrophages and the colonic microbiome, however, were the
focus of Metchnikoff ’s most innovative thinking with regard to
mechanisms responsible for senility. He believed that virtually all
of the disabilities of old age are the work of phagocytes trans-
formed from defenders against infection into destroyers of healthy
tissues by autotoxins derived from putrefactive bacteria residing in
the colon. According to his concept, senile degeneration of the
nervous system, for example, is the work of neurophags induced
by autotoxins to devour the contents of nerve cells and cause them
to atrophy; the blanching of aging hair, the work of similarly
activated chromophags; muscle atrophy, the work of sarcophags;
osteoporosis, the work of osteophags (osteoclasts), and so on. Such
degenerative changes, he believed were nearly always premature
and potentially prevented by measures directed against the colon’s
putrefactive bacteria (2).
Metchnikoff dismissed the human colon as a “vestigial
cesspool” that functions as little more than a reservoir for waste
matter in which microbes produce “fermentations and putrefac-
tion harmful to the host.” Production of autotoxins by the colonic
microbiome, he believed, is amplified by the western diet, and
that avoiding alcohol and foods “such as rich meats and raw or
badly cooked substances containing microbes” might diminish
colonic bacterial production of the noxious ptomaines (alkaloids)
responsible for premature senility. Others tried unsuccessfully to
completely eradicate the colonic microbiome and its autotoxins
by removing the colon or by administering antibacterial ene-
mas. Metchnikoff advised against such measures. He believed
that the evils of autointoxication are best mitigated by inhibit-
ing the putrefactive bacteria in the colon with lactate-producing
bacteria (2).
The specific regimen recommended by Metchnikoff for sup-
pressing putrefactive colonic bacteria consisted of daily doses of
probiotics in the form of “soured milk (i.e., yogurt) prepared by
a group of lactic bacteria, or of pure cultures of the Bulgarian
bacillus (Lactobacillus bulgaricus), but in each case (accompanied
by) a certain quantity of milk, sugar, or sucrose.” He followed his
own advice as a regular part of his diet and was “very well pleased
with the result.” What, exactly, he meant by “very pleased with the
results” is not clear. Possibly, he was encouraged by a diminution of
“sulfo-conjugate ethers”in his urine,which were then monitored as
surrogate markers for intestinal putrefaction. Several of his friends
who “suffered from maladies of the intestine or kidneys” followed
his example and, likewise, were “well satisfied” with the results.
The efficacy of his treatment in retarding the onset of senility was
never validated scientifically (2). Moreover, subsequent work by a
host of investigators showed that L. bulgaricus is unable to survive
in the human intestine or that of any other animal studied and,
hence, not capable of replacing putrefactive bacteria in the colon
(6). L. acidophilus, however, can live in the human intestine and
has been used with limited success as a probiotic.
The FAO/WHO (Food and Agriculture Organization of the
United Nations and the World health Organization) defines pro-
biotics as “live microorganisms which when administered in ade-
quate amounts confer a health benefit on the host (7).” As noted
above, interest in probiotics such as lactobacilli has soared in recent
years, with many studies purporting to demonstrate their effi-
cacy in alleviating human disease, and many more testimonials
extolling their benefits. Nevertheless, according to the Cochrane
Summaries3, evidence supporting such claims is limited to just a
few conditions. Probiotics have been shown to be effective or possi-
bly effective in preventing pediatric antibiotic-associated diarrhea,
necrotizing enterocolitis in preterm infants, and upper respiratory
tract infections. They have been shown to be effective or possi-
bly effective in treating acute infectious diarrhea and persistent
diarrhea in children. To date, probiotics, such as L. acidophilus,
have not been shown to be effective against bacterial vaginosis,
ulcerative colitis, Crohn’s disease, or preterm labor (2).
Fecal transplantation is a special form of probiotic therapy
in which a healthy donor’s fecal microbiota in its entirety (i.e.,
processed stool) is transplanted into the intestine of a patient
suffering with one of various intestinal disorders. The proce-
dure was first performed in 1958 in patients with fulminate
pseudomembranous enterocolitis (8). The results were immedi-
ate and spectacularly successful. Today patients with the same
disorder – now known as “Clostridium difficile enterocolitis” –
respond favorably to such therapy over 90% of the time. The
remarkable success of fecal transplantation in such patients has
raised hope that it might also be used to alleviate or prevent other
intestinal disorders, such as inflammatory bowel disease, irrita-
ble bowel disease, colorectal cancer, and certain nutritional and
metabolic disorders (9). However, to date, evidence supporting
the efficacy of fecal transplantation against any of these disorders
is lacking.
Metchnikoff ’s recommended use of a probiotic to delay the
onset of senility, while never embraced by mainstream medicine,
has been resurrected by fringe elements like Body Ecology, which
promote a “back to basics approach to restoring health (10).” They
3http://summaries.cochrane.org/search/site/probiotics/systematic
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claim that probiotics help one “age gracefully,” without revealing
the mechanism by which such benefit might be brought about.
Metchnikoff was not a physician. However, he believed as physi-
cians do today, that death is rarely if ever “natural,” but in nearly
all cases is the result of either an accident or some treatable or
potentially preventable disease. He maintained that if these can
be avoided, one might expect to survive the full extent of the
human life cycle (orthobiosis) before at last succumbing to “nat-
ural death.” The number of years actually comprising the normal
human life cycle has long been a source of speculation and debate.
In the United States today, the life expectancy for men is 75.9 years,
and for women 80.7 years, averages which have risen steadily
for many decades (11). But do they represent “orthobiosis” –
the maximum number of years a man or a woman can expect
to survive if not killed by an accident or disease? Metchnikoff
thought not. He believed that the normal life cycle of humans is
100 years. Some have speculated that the cycle might be as long
as 200 years, given rare reports of persons reaching the ages of
130, 150, and even 185 years of age (2). Whatever the upper limit
of the normal life cycle of humans, Metchnikoff was convinced
that a person could enhance the chances of reaching it by simple,
sober living, and daily consumption of “soured milk” beginning
in childhood and continued thereafter. Personally, he fell well
short of orthobiosis as he envisioned it, dying at age 71 of heart
failure (12).
If Metchnikoff ’s regimen could increase the average life
expectancy, would that be a good thing? The U.S. government,
like governments of other countries, is already hard-pressed to
meet the medical needs of its elderly citizens. If old people were
to live longer, wouldn’t they consume even more of the resources
needed to support the population at large? Metchnikoff brushed
aside such concerns, maintaining that if the causes of precocious
senility were eliminated, it would no longer be necessary to pen-
sion persons at 60 or 70 years of age. If science allowed them to
complete their normal life cycle, given their vast experience, old
persons might benefit rather than burden society by fulfilling their
role as society’s wisest advisers and judges. If old age could be
“postponed so much that men of from 60 to 70 years of age (were
to) retain their vigor. . . young men of 21 years of age (would) no
longer be thought mature or ready to fulfill functions so difficult
as taking a share in public affairs (2).”
The average life expectancy in France during Metchnikoff ’s day
was not much more than 40 years (13). Today in the United States
it is nearly twice that number, as are the number of elderly people
supported by government programs. Whether it would be good
to increase the average life expectancy of Americans further is a
question asked today only in relation to the cost of end-of-life care.
Although death is inevitable, Americans – physicians as well as
laypersons – nearly always view it as unnatural. Thus, like Metch-
nikoff, Americans believe that extending life, in particular, useful,
productive, healthy life, is a good thing. Metchnikoff ’s formula for
doing so is simple, inexpensive, and logical. Unfortunately, there is
little reason to believe that it is capable of producing the optimistic
results he predicted it could.
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